Acerus Pharmaceuticals is Pharmaceuticals in Canada that focus on Acerus Pharmaceuticals Corp business. Founded in 2008. They cover business area such as Acerus Pharmaceuticals Corp, manufacture, marketing, distribution, brand product, its product, brand ESTRACE, NATESTO, GYNOFLOR, tefina, Canada, menopausal symptom, replacement therapy, adult male, hypogonadism, ultra-low dose vaginal estrogen therapy, development, female sexual dysfunction.
2008
( 16 years old in 2024 )
Acerus Pharmaceuticals Corp
-
7025 Langer Drive
Suite 205
Mississauga, Ontario L5N 0E8
Canada
Private
Acerus Pharmaceuticals Corpmanufacturemarketingdistributionbrand productits productbrand ESTRACENATESTOGYNOFLORtefinaCanadamenopausal symptomreplacement therapyadult malehypogonadismultra-low dose vaginal estrogen therapydevelopmentfemale sexual dysfunction
* We use standard office opening hours in near Acerus Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Acerus Pharmaceuticals is Pharmaceuticals business from Canada that founded in 2008 (16 years old in 2024), Acerus Pharmaceuticals business is focusing on Acerus Pharmaceuticals Corp.
Acerus Pharmaceuticals headquarter office and corporate office address is located in 7025 Langer Drive Suite 205 Mississauga, Ontario L5N 0E8 Canada.
Acerus Pharmaceuticals was founded in Canada.
In 2024, Acerus Pharmaceuticals is currently focus on Acerus Pharmaceuticals Corp sector.
Above is snippet of Google Trends for "Acerus Pharmaceuticals Corp" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Acerus Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
